Image

Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.

Investigating Treatment Options for Pancreatic Cancer

Recruiting
18 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates advanced pancreatic cancer. The purpose of this study is to explore the effects of different maintenance treatments for patients who have not shown disease progression after initial chemotherapy.

The study evaluates the effectiveness and safety of two treatment options to determine which one may offer better outcomes for patients. It looks at overall survival rates and other health impacts.

  • Who can participate: Participants must be 18 years or older with advanced pancreatic cancer that cannot be surgically removed. They must have good health status and meet specific health criteria.
  • Study details: Participants will either continue with their current treatment or switch to an investigational medication.
Print
Study details
    Pancreatic Adenocarcinoma Advanced or Metastatic

NCT06897644

Gruppo Oncologico del Nord-Ovest

12 September 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.